Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
21.69
+1.42 (7.01%)
At close: Dec 5, 2025, 4:00 PM EST
21.90
+0.21 (0.97%)
After-hours: Dec 5, 2025, 7:59 PM EST
Keros Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 423 | 641 | 1,191 | 1,323 | 1,369 | 1,635 | |
| Market Cap Growth | -80.51% | -46.17% | -9.94% | -3.39% | -16.27% | - | |
| Enterprise Value | -253 | 130 | 918 | 1,084 | 1,149 | 1,502 | |
| Last Close Price | 21.69 | 15.83 | 39.76 | 48.02 | 58.51 | 70.54 | |
| PS Ratio | 3.56 | 180.63 | 7888.64 | - | 68.11 | - | |
| PB Ratio | 1.25 | 1.12 | 3.59 | 4.77 | 5.63 | 6.25 | |
| P/TBV Ratio | 0.60 | 1.12 | 3.59 | 4.77 | 5.63 | 6.25 | |
| EV/Sales Ratio | - | 36.57 | 6076.87 | - | 57.16 | - | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.04 | 0.05 | 0.00 | 0.00 | |
| Debt / FCF Ratio | 0.20 | - | - | - | - | - | |
| Asset Turnover | 0.37 | 0.01 | 0 | - | 0.08 | - | |
| Quick Ratio | 29.02 | 20.56 | 13.63 | 16.92 | 20.96 | 37.04 | |
| Current Ratio | 29.86 | 21.45 | 14.25 | 17.27 | 21.23 | 37.27 | |
| Return on Equity (ROE) | 10.42% | -41.46% | -50.19% | -40.22% | -23.27% | -34.60% | |
| Return on Assets (ROA) | 4.40% | -26.73% | -31.39% | -25.53% | -13.43% | -20.80% | |
| Return on Capital (ROIC) | 4.56% | -28.12% | -33.33% | -26.82% | -13.90% | -21.65% | |
| Return on Capital Employed (ROCE) | 6.50% | -35.80% | -49.20% | -39.60% | -23.20% | -17.80% | |
| Earnings Yield | 15.23% | -29.22% | -12.84% | -7.91% | -4.29% | -2.77% | |
| FCF Yield | 20.57% | -25.39% | -10.66% | -5.39% | -4.61% | -2.27% | |
| Buyback Yield / Dilution | -17.52% | -27.13% | -16.66% | -8.17% | -50.48% | -566.41% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.